Recent posts
Microfluidic-Based POC Device for Detection and Analysis of HIV Directly From Blood Client/Summary Chipcare, a biotech company specializing in multiplexed Point-of-Care (POC) diagnostics for sexually transmitted infections, approached Gener8 to develop a turnkey sample-to-answer POC device and microfluidic-based cartridge for analyzing blood from HIV patients. The goal was to create…
Read more
Gener8 Celebrates 20 Years of Business and Continued Growth Sunnyvale, California – September 16th, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), celebrates the company’s 20th anniversary this month. Since its founding in September 2002 Gener8 has developed into a full product lifecycle engineering and…
Read more
Sunnyvale, California – February 9, 2022 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), welcomes Mark Chatfield as the new Global Vice President of Operations. Mark brings thirty years of experience with Thermo Fisher Scientific running operations in the fields of specialized x-rays, chromatography, and mass…
Read more
Sunnyvale, California – December 9, 2021 Gener8 LLC (“Gener8”), a portfolio company of Sverica Capital Management LP (“Sverica”), announced today that it has completed its acquisition of the RND Group (“RND”), a leading provider of software development focused on medical device and life science products, based in Indianapolis, Indiana. With…
Read more
SUNNYVALE, Calif., June 30, 2021, Gener8 LLC (“Gener8”), a provider of full product lifecycle engineering and manufacturing solutions for highly complex instruments and products within the life sciences and medical device markets, together with its capital partner, Sverica Capital Management LP, is restructuring its 15,000 sq. ft. Carlsbad facility to provide microfluidics cartridge design,…
Read more